Search for other papers by Hyun-Ah Kim in
Google Scholar
PubMed
Search for other papers by Jihye Choi in
Google Scholar
PubMed
Search for other papers by Chan Sub Park in
Google Scholar
PubMed
Search for other papers by Min-Ki Seong in
Google Scholar
PubMed
Search for other papers by Sung-Eun Hong in
Google Scholar
PubMed
Search for other papers by Jae-Sung Kim in
Google Scholar
PubMed
Search for other papers by In-Chul Park in
Google Scholar
PubMed
Search for other papers by Jin Kyung Lee in
Google Scholar
PubMed
Search for other papers by Woo Chul Noh in
Google Scholar
PubMed
Search for other papers by the ASTRRA trial investigators in
Google Scholar
PubMed
strategy for young hormone receptor-positive breast cancer patients with chemotherapy-induced amenorrhoea. In the evaluation of infertility, anti-Müllerian hormone (AMH), inhibin B, oestradiol, follicular-stimulating hormone (FSH) and luteinising hormone
Search for other papers by Pamela Stratton in
Google Scholar
PubMed
Search for other papers by Neelam Giri in
Google Scholar
PubMed
Search for other papers by Sonia Bhala in
Google Scholar
PubMed
Search for other papers by Martha M Sklavos in
Google Scholar
PubMed
Search for other papers by Blanche P Alter in
Google Scholar
PubMed
Search for other papers by Sharon A Savage in
Google Scholar
PubMed
Search for other papers by Ligia A Pinto in
Google Scholar
PubMed
the general population, although the risk in DBA is not as high as in FA or DC/TBD ( 4 ). Anti-Müllerian hormone (AMH) is a glycoprotein in the transforming growth factor-β (TGF-β) superfamily ( 16 , 17 ). AMH is a key factor in cell proliferation
Search for other papers by Xiying Zeng in
Google Scholar
PubMed
Search for other papers by Yinxiang Huang in
Google Scholar
PubMed
Search for other papers by Mulin Zhang in
Google Scholar
PubMed
Search for other papers by Yun Chen in
Google Scholar
PubMed
Search for other papers by Jiawen Ye in
Google Scholar
PubMed
Search for other papers by Yan Han in
Google Scholar
PubMed
Search for other papers by Danyan Ma in
Google Scholar
PubMed
Search for other papers by Xin Zheng in
Google Scholar
PubMed
Search for other papers by Xiaohong Yan in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, The First Affiliated Hospital, Xiamen University, Xiamen, China
Fujian Province Key Laboratory of Diabetes Translational Medicine, Xiamen, China
Search for other papers by Changqin Liu in
Google Scholar
PubMed
, obesity has represented a major burden for women with PCOS. Weight loss has been shown to improve both the reproductive and metabolic features of PCOS ( 6 ). Anti-Müllerian hormone (AMH) is a peptide growth factor, which belongs to the transforming
Search for other papers by R H M Dykgraaf in
Google Scholar
PubMed
Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Search for other papers by S Schalekamp-Timmermans in
Google Scholar
PubMed
Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Search for other papers by M C Adank in
Google Scholar
PubMed
Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Search for other papers by S A A van den Berg in
Google Scholar
PubMed
Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Search for other papers by B M N van de Lang-Born in
Google Scholar
PubMed
Search for other papers by T I M Korevaar in
Google Scholar
PubMed
Search for other papers by A Kumar in
Google Scholar
PubMed
Search for other papers by B Kalra in
Google Scholar
PubMed
Search for other papers by G V Savjani in
Google Scholar
PubMed
Division of Obstetrics and Fetal Medicine, Department of Obstetrics and Gynecology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Search for other papers by E A P Steegers in
Google Scholar
PubMed
Search for other papers by Y V Louwers in
Google Scholar
PubMed
Search for other papers by J S E Laven in
Google Scholar
PubMed
Introduction Anti‐Müllerian hormone (AMH) is a glycoprotein from the transforming growth factor‐beta family and is produced by granulosa cells of antral and preantral follicles ( 1 , 2 ). AMH plays an important role in ovarian function and
Search for other papers by Hui Long in
Google Scholar
PubMed
Search for other papers by Yanhong Nie in
Google Scholar
PubMed
Search for other papers by Li Wang in
Google Scholar
PubMed
Search for other papers by Yong Lu in
Google Scholar
PubMed
Search for other papers by Yan Wang in
Google Scholar
PubMed
Search for other papers by Yijun Cai in
Google Scholar
PubMed
Search for other papers by Zhen Liu in
Google Scholar
PubMed
Search for other papers by Miaomiao Jia in
Google Scholar
PubMed
Search for other papers by Qifeng Lyu in
Google Scholar
PubMed
Search for other papers by Yanping Kuang in
Google Scholar
PubMed
Search for other papers by Qiang Sun in
Google Scholar
PubMed
cycle, ## P < 0.001. AMH, anti-Mullerian hormone; MII, metaphase II. Correlations of age, AMH and oocyte outcomes To determine the effect of ovarian stimulation on AMH level, samples from the monkeys who received repeated ovarian
School of Women’s & Children’s Health, Discipline of Obstetrics and Gynaecology, University of New South Wales, Sydney, Australia
Search for other papers by David Mark Robertson in
Google Scholar
PubMed
Search for other papers by Chel Hee Lee in
Google Scholar
PubMed
Search for other papers by Angela Baerwald in
Google Scholar
PubMed
Shah S Pruysers E Vanden Brink H Chizen D Visser JA Themmen AP Baerwald A. Detection of serum antimullerian hormone in women approaching menopause using sensitive anti-mullerian hormone enzyme-linked immunosorbent assays
Search for other papers by Iben Katinka Greiber in
Google Scholar
PubMed
Search for other papers by Casper P Hagen in
Google Scholar
PubMed
Search for other papers by Alexander Siegfried Busch in
Google Scholar
PubMed
Search for other papers by Mikkel Grunnet Mieritz in
Google Scholar
PubMed
Search for other papers by Lise Aksglæde in
Google Scholar
PubMed
Search for other papers by Katharina Main in
Google Scholar
PubMed
Search for other papers by Kristian Almstrup in
Google Scholar
PubMed
Search for other papers by Anders Juul in
Google Scholar
PubMed
Introduction Anti-Müllerian hormone (AMH) is produced by immature Sertoli cells in the male and in granulosa cells in preantral and small antral follicles in the female ( 1 , 2 ). AMH is a glycoprotein hormone belonging to the TGF
Search for other papers by Agnieszka Adamska in
Google Scholar
PubMed
Search for other papers by Paulina Tomczuk-Bobik in
Google Scholar
PubMed
Search for other papers by Anna Beata Popławska-Kita in
Google Scholar
PubMed
Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed
Search for other papers by Angelika Buczyńska in
Google Scholar
PubMed
Search for other papers by Piotr Szumowski in
Google Scholar
PubMed
Search for other papers by Łukasz Żukowski in
Google Scholar
PubMed
Search for other papers by Janusz Myśliwiec in
Google Scholar
PubMed
Search for other papers by Monika Zbucka-Krętowska in
Google Scholar
PubMed
Search for other papers by Marcin Adamski in
Google Scholar
PubMed
Clinical Research Centre, Medical University of Bialystok, Białystok, Poland
Search for other papers by Adam Jacek Krętowski in
Google Scholar
PubMed
hormonal markers, dynamic tests, and ultrasonographic (USG) parameters, for example, antral follicle count (AFC). Markers such as the serum levels of anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), or inhibin B are relatively good
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Trine Holm Johannsen in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jakob Albrethsen in
Google Scholar
PubMed
Search for other papers by Vassos Neocleous in
Google Scholar
PubMed
Search for other papers by Federico Baronio in
Google Scholar
PubMed
Search for other papers by Martine Cools in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Lise Aksglaede in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Niels Jørgensen in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Peter Christiansen in
Google Scholar
PubMed
Pediatric Endocrinology Clinic, Department of Pediatrics, Aretaeio Hospital, Nicosia, Cyprus
Search for other papers by Meropi Toumba in
Google Scholar
PubMed
Search for other papers by Pavlos Fanis in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Marie Lindhardt Ljubicic in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
testosterone, inhibin B and anti-Müllerian hormone (AMH). Elevated concentrations of adrenal androgens may result in testosterone concentrations within the reference range despite low LH and FSH concentrations in CAH patients. Thus, additional markers of Leydig
Search for other papers by Angela Köninger in
Google Scholar
PubMed
Search for other papers by Philippos Edimiris in
Google Scholar
PubMed
Search for other papers by Laura Koch in
Google Scholar
PubMed
Search for other papers by Antje Enekwe in
Google Scholar
PubMed
Search for other papers by Claudia Lamina in
Google Scholar
PubMed
Search for other papers by Sabine Kasimir-Bauer in
Google Scholar
PubMed
Search for other papers by Rainer Kimmig in
Google Scholar
PubMed
Department of Gynecology and Obstetrics, Division of Genetic Epidemiology, Vitateq Biotechnology GmbH, University of Duisburg-Essen, D-45122 Essen, Germany
Search for other papers by Hans Dieplinger in
Google Scholar
PubMed
parameters of oxidative stress such as ‘advanced glycosylation end products’ correlated strongly with anovulation, follicle number, and concentrations of anti-Müllerian hormone (AMH) in patients with PCOS (3) . Although insulin resistance (IR) plays an